Home / Companies / Teva Pharmaceutical Industries Limited / 6 Jun 2024
Teva Pharmaceutical Industries Limited: meeting of 6 Jun 2024
Votes reported on Form N-PX, item by item
94 Form N-PX filers reported votes at the Teva Pharmaceutical Industries Limited meeting of 6 Jun 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
4 nominees; 90.2% of reported votes for; 10 filers withheld from or voted against at least one nominee.
184 vote records from 30 filers. 0 of the 30 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
134 vote records from 91 filers. 28 of the 90 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Frequency of the say-on-pay vote
one year: 75 filers; for: 5 filers; three years: 2 filers; against: 1 filer; take no action: 1 filer; abstain: 1 filer.
138 vote records from 86 filers. 4 of the 82 filers that marked the item either way voted against management. 4 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
46 vote records from 30 filers. 0 of the 30 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
27 vote records from 6 filers. No filer marked a management recommendation, so no against-management figure is reported. 6 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Pay-vote frequency | 4. Auditor |
|---|---|---|---|---|
| Vanguard | For | For | Split or no vote | For |
| BlackRock and iShares | No report | For | Split or no vote | No report |
| Dimensional | No report | For | Split or no vote * | No report |
| State Street and SPDR | For | Against * | Split or no vote | For |
| American Century | For | For | Split or no vote | For |
| Franklin Templeton | No report | For | Split or no vote | No report |
| Invesco | For | For | Split or no vote | For |
| John Hancock and Manulife | For | For | Split or no vote | For |
| J.P. Morgan | For | For | Split or no vote | For |
| Goldman Sachs | No report | For | Split or no vote | No report |
| Jackson National funds | For | For | For | For |
| Northern Trust and FlexShares | For | For | Split or no vote | For |
| T. Rowe Price | No report | For | Split or no vote | No report |
| Lincoln Financial | For | Against * | Split or no vote | For |
| First Trust | For | For | Split or no vote | For |
| Victory Capital | For | For | Split or no vote | For |
| Brighthouse Funds | Split or no vote | No report | No report | For |
| Columbia Threadneedle | No report | For | Split or no vote | No report |
| BNY Mellon | For | For | Split or no vote | For |
| Capital Group and American Funds | No report | For | Split or no vote | No report |
| AllianceBernstein | No report | For | Split or no vote | No report |
| Macquarie and Delaware Funds | No report | For | Split or no vote | No report |
| Janus Henderson | No report | For | Split or no vote | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Teva Pharmaceutical Industries Limited meeting?
94 Form N-PX filers reported votes at the meeting of 6 Jun 2024. On say-on-pay, 28 of 90 voted against management (31.1%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Teva Pharmaceutical Industries Limited on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Teva Pharmaceutical Industries Limited
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Teva Pharmaceutical Industries Limited with a meeting date within three days of 6 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.